Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00958659 · ClinicalTrials.gov registry record
Study of Specimens From Young Patients With Neuroblastoma
A clinical trial, sponsored by Children's Oncology Group.
- Completed
- Registry status
- 350
- Enrollment target
NCT00958659: Completed study, sponsored by Children's Oncology Group.
NCT00958659 is a clinical trial that has completed, run by Children's Oncology Group. The registered enrollment target is 350 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00958659 has completed, sponsored by Children's Oncology Group.
- COMPLETED
- Registry status
- 350 participants
- Enrollment target
Study Summary
This research trial studies specimens from young patients with neuroblastoma. Studying the genes expressed in specimens from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
Primary Outcome
Multivariate logistic regression analyses will be performed to determine if the mRNA expression signature is a significant independent predictor after controlling for currently used risk factors.
Interventions
- OTHER laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 350 participants |
| Start Date | 2008-12 |
| Est. Completion | 2016-05 |
What the finished NCT00958659 record still lists
NCT00958659 is an observational study that tracks outcomes without assigning an intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which laboratory biomarker analysis is the first listed.
NCT00958659 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00958659 about?
NCT00958659 is a clinical study titled "Study of Specimens From Young Patients With Neuroblastoma". This research trial studies specimens from young patients with neuroblastoma. Studying the genes expressed in specimens from patients with cancer may help doctors identify biomarkers related to cancer. It may also help doctors predict how patients will respond to treatment.
What is the current status of trial NCT00958659?
This trial is currently completed. The enrollment target is 350 participants. The study started on 2008-12. Estimated completion is 2016-05.
What interventions are being tested in trial NCT00958659?
The interventions under investigation include: laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00958659?
This trial is sponsored by Children's Oncology Group, which has 342 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00900575 · 350 participants · NA
Cervical Cancer Detection Using Optical Spectroscopy
- NCT01627821 · 350 participants · NA
Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study
- NCT02357654 · 350 participants · Phase 4
GnRH for Luteal Support in IVF/ICSI/FET Cycles
- NCT03997370 · 350 participants · Phase 1
Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia